8.10
price up icon0.87%   0.07
after-market After Hours: 8.08 -0.02 -0.25%
loading
Enanta Pharmaceuticals Inc stock is traded at $8.10, with a volume of 123.69K. It is up +0.87% in the last 24 hours and up +8.00% over the past month. Enanta Pharmaceuticals Inc is an American biotechnology company which uses robust, chemistry-driven approach and drug discovery capabilities to focus on the research and development of molecule drugs to cure viral infections and liver diseases. Uses virology and immunology method for curing the diseases. The targeted diseases are hepatitis C, hepatitis B, nonalcoholic steatohepatitis, and the respiratory syncytial virus. The novelty of company research is a specific direct-acting antiviral inhibitor against the hepatitis C virus. The company's inhibitors have been developed in collaboration with AbbVie. AbbVie markets the protease inhibitor, paritaprevir, while other inhibitors are in the pipeline.
See More
Previous Close:
$8.03
Open:
$8.01
24h Volume:
123.69K
Relative Volume:
0.77
Market Cap:
$173.15M
Revenue:
$66.59M
Net Income/Loss:
$-104.93M
P/E Ratio:
-1.6364
EPS:
-4.95
Net Cash Flow:
$-96.48M
1W Performance:
+5.61%
1M Performance:
+8.00%
6M Performance:
+62.65%
1Y Performance:
-47.30%
1-Day Range:
Value
$7.86
$8.15
1-Week Range:
Value
$7.15
$8.17
52-Week Range:
Value
$4.09
$15.92

Enanta Pharmaceuticals Inc Stock (ENTA) Company Profile

Name
Name
Enanta Pharmaceuticals Inc
Name
Phone
617 607 0800
Name
Address
4 KINGSBURY AVENUE, WATERTOWN, MA
Name
Employee
131
Name
Twitter
@EnantaPharma
Name
Next Earnings Date
2025-02-10
Name
Latest SEC Filings
Name
ENTA's Discussions on Twitter

Compare ENTA with other stocks

Stocks Price Market Cap Revenue Net Income Cash Flow EPS
Biotechnology icon
ENTA
Enanta Pharmaceuticals Inc
8.10 171.65M 66.59M -104.93M -96.48M -4.95
Biotechnology icon
VRTX
Vertex Pharmaceuticals Inc
468.41 118.34B 11.10B -988.90M -1.26B -3.92
Biotechnology icon
REGN
Regeneron Pharmaceuticals Inc
558.14 60.31B 14.09B 4.50B 2.96B 39.28
Biotechnology icon
ALNY
Alnylam Pharmaceuticals Inc
330.55 42.35B 2.35B -269.70M -75.39M -2.09
Biotechnology icon
ARGX
Argen X Se Adr
598.79 36.43B 2.58B 1.06B -1.28B 16.33
Biotechnology icon
ONC
Beone Medicines Ltd Adr
305.74 31.87B 3.81B -644.79M -669.77M -6.24

Enanta Pharmaceuticals Inc Stock (ENTA) Upgrades & Downgrades

Date Action Analyst Rating Change
Aug-09-23 Downgrade JP Morgan Neutral → Underweight
Aug-08-23 Downgrade Jefferies Buy → Hold
Dec-09-22 Initiated H.C. Wainwright Buy
Jul-06-22 Upgrade Evercore ISI In-line → Outperform
Jun-01-22 Upgrade Evercore ISI Underperform → In-line
Oct-07-21 Initiated Jefferies Buy
Sep-09-21 Initiated SVB Leerink Mkt Perform
Jan-29-21 Upgrade JP Morgan Underweight → Neutral
Nov-24-20 Initiated Evercore ISI Underperform
Aug-28-20 Resumed ROTH Capital Buy
Aug-26-20 Initiated Piper Sandler Overweight
Jul-27-20 Upgrade JMP Securities Mkt Perform → Mkt Outperform
Mar-17-20 Upgrade Robert W. Baird Neutral → Outperform
Nov-22-19 Downgrade JMP Securities Mkt Outperform → Mkt Perform
Sep-26-19 Downgrade JP Morgan Neutral → Underweight
May-24-19 Initiated Wolfe Research Outperform
Apr-23-19 Upgrade Berenberg Hold → Buy
Dec-13-18 Initiated Berenberg Hold
Jun-06-18 Initiated ROTH Capital Buy
Feb-08-18 Downgrade JP Morgan Overweight → Neutral
Jan-02-18 Downgrade RBC Capital Mkts Outperform → Sector Perform
Nov-21-17 Reiterated RBC Capital Mkts Outperform
Sep-15-17 Initiated RBC Capital Mkts Outperform
Jul-11-17 Upgrade JMP Securities Mkt Perform → Mkt Outperform
Apr-28-16 Downgrade JMP Securities Mkt Outperform → Mkt Perform
Feb-09-16 Reiterated Barclays Underweight
Oct-23-15 Downgrade Barclays Equal Weight → Underweight
Oct-23-15 Upgrade JMP Securities Mkt Perform → Mkt Outperform
View All

Enanta Pharmaceuticals Inc Stock (ENTA) Latest News

pulisher
Jul 29, 2025

How institutional ownership impacts Enanta Pharmaceuticals Inc. stockPattern Recognition Tool for ROI Investors - Newser

Jul 29, 2025
pulisher
Jul 29, 2025

Can a trend reversal in Enanta Pharmaceuticals Inc. lead to recoveryPredictive Screener for Daily Trade Watch - Newser

Jul 29, 2025
pulisher
Jul 29, 2025

Enanta Pharmaceuticals Inc. Stock Chart Analysis: Bullish or Bearish Pattern FormingWeekly Growth Portfolio Performance Summary - Newser

Jul 29, 2025
pulisher
Jul 29, 2025

What makes Enanta Pharmaceuticals Inc. stock price move sharplyMomentum Trading Guide with Safety Limits - Newser

Jul 29, 2025
pulisher
Jul 29, 2025

Enanta Pharmaceuticals Inc. stock prediction for this weekROI Prediction from Long-Term Holding Plans - Newser

Jul 29, 2025
pulisher
Jul 29, 2025

Can volume confirm reversal in Enanta Pharmaceuticals Inc.Risk/Reward Optimization Entry Point Analysis - Newser

Jul 29, 2025
pulisher
Jul 29, 2025

Will Enanta Pharmaceuticals Inc. stock benefit from interest rate changesFree Fundamental + Technical Hybrid Stock Tips - Newser

Jul 29, 2025
pulisher
Jul 29, 2025

How Interest Rate Changes Impact Enanta Pharmaceuticals Inc. Stock PerformanceFree Early Entry Tips With Low Risk Zone - Newser

Jul 29, 2025
pulisher
Jul 29, 2025

Will Enanta Pharmaceuticals Inc. Stock Benefit from AI and Green Energy TrendsMachine Learning Stock Price Forecast Tool - Newser

Jul 29, 2025
pulisher
Jul 29, 2025

How Enanta Pharmaceuticals Inc. stock performs during market volatilityDaily Entry Opportunity Forecasting Tool - Newser

Jul 29, 2025
pulisher
Jul 28, 2025

Is Enanta Pharmaceuticals Inc. a growth stock or a value stockBeginner Investor Growth Plan For Every Investor - jammulinksnews.com

Jul 28, 2025
pulisher
Jul 28, 2025

Does Enanta Pharmaceuticals Inc. stock perform well during market downturnsUnlock exclusive stock market forecasts - jammulinksnews.com

Jul 28, 2025
pulisher
Jul 28, 2025

What institutional investors are buying Enanta Pharmaceuticals Inc. stockGet real-time updates on market trends - jammulinksnews.com

Jul 28, 2025
pulisher
Jul 28, 2025

How does Enanta Pharmaceuticals Inc. compare to its industry peersGet daily updates on the hottest stocks - jammulinksnews.com

Jul 28, 2025
pulisher
Jul 28, 2025

Enanta Pharmaceuticals stock receives Buy rating from H.C. Wainwright By Investing.com - Investing.com Canada

Jul 28, 2025
pulisher
Jul 28, 2025

Is Enanta Pharmaceuticals Inc. stock overvalued or undervaluedInvest smarter with actionable stock recommendations - jammulinksnews.com

Jul 28, 2025
pulisher
Jul 28, 2025

What are Enanta Pharmaceuticals Inc. company’s key revenue driversRapid-fire capital growth - jammulinksnews.com

Jul 28, 2025
pulisher
Jul 27, 2025

What catalysts could drive Enanta Pharmaceuticals Inc. stock higher in 2025Identify undervalued stocks ready to soar - jammulinksnews.com

Jul 27, 2025
pulisher
Jul 27, 2025

What is Enanta Pharmaceuticals Inc. company’s growth strategyFree Smart Trading Workshop - jammulinksnews.com

Jul 27, 2025
pulisher
Jul 27, 2025

Is it the right time to buy Enanta Pharmaceuticals Inc. stockOverwhelming financial success - jammulinksnews.com

Jul 27, 2025
pulisher
Jul 27, 2025

How many analysts rate Enanta Pharmaceuticals Inc. as a “Buy”Invest smarter with actionable stock recommendations - jammulinksnews.com

Jul 27, 2025
pulisher
Jul 27, 2025

Enanta Pharmaceuticals Inc. Company’s Quarterly Earnings Growth: What the Numbers SayFree Step-by-Step Investment Guide - Newser

Jul 27, 2025
pulisher
Jul 27, 2025

Intrinsic Value of Enanta Pharmaceuticals Inc. Stock: Is It Undervalued or OvervaluedWealth Accumulation Stock List - Newser

Jul 27, 2025
pulisher
Jul 27, 2025

Enanta Pharmaceuticals Inc. Company Revenue and Profit Trends: A Deep DiveFast Gains With Reduced Risk - Newser

Jul 27, 2025
pulisher
Jul 27, 2025

Has Enanta Pharmaceuticals Inc. Stock Ever Crashed Historical Volatility ReviewLow Risk Consistent Winners - Newser

Jul 27, 2025
pulisher
Jul 25, 2025

What drives Enanta Pharmaceuticals Inc. stock priceStrong return on investment - Autocar Professional

Jul 25, 2025
pulisher
Jul 25, 2025

One Enanta Pharmaceuticals Insider Raised Their Stake In The Previous Year - Yahoo Finance

Jul 25, 2025
pulisher
Jul 25, 2025

What analysts say about Enanta Pharmaceuticals Inc. stockJaw-dropping returns - Autocar Professional

Jul 25, 2025
pulisher
Jul 25, 2025

Is Enanta Pharmaceuticals Inc. a good long term investmentMarket-crushing stock picks - PrintWeekIndia

Jul 25, 2025
pulisher
Jul 23, 2025

Enanta Pharmaceuticals Inc. Stock Analysis and ForecastConsistent wealth multiplication - jammulinksnews.com

Jul 23, 2025

Enanta Pharmaceuticals Inc Stock (ENTA) Financials Data

Revenue

loading

Net Income

loading

Cash Flow

loading

EPS

loading
$77.38
price up icon 10.28%
$37.27
price up icon 0.57%
$105.00
price up icon 3.19%
$26.74
price down icon 2.59%
$111.48
price down icon 1.16%
biotechnology ONC
$305.74
price up icon 3.81%
Cap:     |  Volume (24h):